the Prevention of Bone Marrow Suppression Caused by Chemotherapy in Advanced NSCLC With Trilaciclib

NCT06370416 · clinicaltrials.gov ↗

PHASE2

Phase

ENROLLING_BY_INVITATION

Status

41

Enrollment

OTHER_GOV

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG: Trilaciclib

Sponsor

Henan Cancer Hospital

Collaborators

[object Object]